以下のリンクよりご確認ください。（別ウィンドウが開きます）
▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Review
——————————
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
Hayato Tada, et al., J Atheroscler Thromb, 2021; 28: 305-313.
——————————
Editorials
——————————
Unraveling the Effects of Trimethylamine N-Oxide on Stroke: “The lower, the better?”
Tomoya Yamashita, et al., J Atheroscler Thromb, 2021; 28: 314-316.
Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) on Lipid Metabolism and Insulin Resistance in Human
Isao Muraki, J Atheroscler Thromb, 2021; 28: 317-318.
Screening for Aortic Aneurysm: Further Evidence is Required to Clarify the Issue
Atsushi Hozawa, J Atheroscler Thromb, 2021; 28: 319.
——————————
Original Articles
——————————
Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
Taoping Sun, et al., J Atheroscler Thromb, 2021; 28: 320-328.
Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population
Hitoshi Hamamura , et al., J Atheroscler Thromb, 2021; 28: 329-337.
Body Mass Index and Mortality From Aortic Aneurysm and Dissection
Midori Takada, et al., J Atheroscler Thromb, 2021; 28: 338-348.
Feasibility and Safety of the Direct Occluded Vessel Puncture Technique as a New Access Site for Complex Peripheral Artery Occlusive Disease
Daizo Kawasaki, et al., J Atheroscler Thromb, 2021; 28: 349-355.
Intracranial Calcification is Predictive for Hemorrhagic Transformation and Prognosis After Intravenous Thrombolysis in Non-Cardioembolic Stroke Patients
Yao Yu, et al., J Atheroscler Thromb, 2021; 28: 356-364.
IVUS-Guided Wiring Improves the Clinical Outcomes of Angioplasty for Long Femoropopliteal CTO Compared with the Conventional Intraluminal Approach
Yoshinori Tsubakimoto, et al., J Atheroscler Thromb, 2021; 28: 365-374.
Abstract/ PDF
ALK7 Acts as a Positive Regulator of Macrophage Activation through Down-Regulation of PPARγ Expression
Wen-Lin Cheng, et al., J Atheroscler Thromb, 2021; 28: 375-384.
Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
Shigeru Tanaka, et al., J Atheroscler Thromb, 2021; 28: 385-395.
——————————
Case Report
——————————
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome
Masaki Hayakawa, et al., J Atheroscler Thromb, 2021; 28: 396-401.
——————————
Correspondence
——————————
Etiology and Management of Bleeding during ECMO in a COVID-19 Patient
Shinya Yamada, et al., J Atheroscler Thromb, 2021; 28: 402-403.
——————————
Author’s Reply
——————————
Response to “Etiology and Management of Bleeding during ECMO in a COVID-19 Patient”
Masaki Hayakawa and Masanori Matsumoto, J Atheroscler Thromb, 2021; 28: 404-405.
——————————
Report
——————————
COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020
Hisanori Horiuchi, et al., J Atheroscler Thromb, 2021; 28: 406-416.